CELLIPONT BIOSERVICES AND ERNEXA THERAPEUTICS ENTER CELL THERAPY MANUFACTURING PARTNERSHIP TO ADVANCE ERNA-101 TOWARD CLINICAL TRIALS IN OVARIAN CANCER

Reuters · 10/29/2025 12:33

Please log in to view news
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.